Literature DB >> 6134582

Reconfirmation of indirect induction of radiogenic lymphomas using thymectomized, irradiated B10 mice grafted with neonatal thymuses from Thy 1 congenic donors.

M Muto, T Sado, I Hayata, F Nagasawa, H Kamisaku, E Kubo.   

Abstract

An experiment was conducted to reexamine earlier observations that lymphomas could develop from lymphocytes present in nonirradiated thymuses grafted into thymectomized, fractionally (170 R, 4 doses) irradiated mice by using B10. Thy 1 congenic donor-host combinations. The results indicated that: (a) 37 of 91 thymectomized, fractionally irradiated B10. Thy 1.2 mice which were grafted s.c. with 7-day-old thymuses from B10. Thy 1.1 donor mice had developed frank lymphomas between 90 and 270 days after thymus grafting; (b) 28 of 37 lymphomas developed in this group were typed individually with respect to Thy 1 alloantigens by the cytotoxicity assay using monoclonal anti-Thy 1.1 (T-11-D7) and anti-Thy 1.2 (F7D5) antibodies plus complement. It was shown that 21 thymic lymphomas (75%) had originated from lymphocytes of the nonirradiated thymus grafts and 5 tumors (17.9%) from cells of the irradiated hosts; 2 thymic lymphomas (7.1%) manifested no Thy 1 antigens; (c) lymphoma cells originated from both nonirradiated thymus grafts and irradiated hosts possessed chromosome abnormalities, which were mainly numerical changes of some chromosomes or polyploidizations.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6134582

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

1.  Homotypic aggregation of murine T lymphocytes induced by anti-Thy-1 monoclonal antibodies.

Authors:  K Isobe; I Nakashima
Journal:  Immunology       Date:  1991-06       Impact factor: 7.397

2.  Induction of cutaneous graft-versus-host disease by local injection of unprimed T cells.

Authors:  K Kawai; Y Matsumoto; H Watanabe; M Ito; M Fujiwara
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

Review 3.  Mouse models for radiation-induced cancers.

Authors:  Leena Rivina; Michael J Davoren; Robert H Schiestl
Journal:  Mutagenesis       Date:  2016-05-21       Impact factor: 3.000

4.  Expansion of intermediate T-cell receptor cells in mice with autoimmune-like graft-versus-host disease.

Authors:  Y Ikarashi; T Abo; K Kawai; T IIai; H Watanabe; K Suzuki; Y Matsumoto; S Omata; M Fujiwara
Journal:  Immunology       Date:  1994-10       Impact factor: 7.397

Review 5.  Mouse models for efficacy testing of agents against radiation carcinogenesis—a literature review.

Authors:  Leena Rivina; Robert Schiestl
Journal:  Int J Environ Res Public Health       Date:  2012-12-27       Impact factor: 3.390

6.  Nature of nontargeted radiation effects observed during fractionated irradiation-induced thymic lymphomagenesis in mice.

Authors:  Hideo Tsuji; Hiroko Ishii-Ohba; Tadahiro Shiomi; Naoko Shiomi; Takanori Katsube; Masahiko Mori; Mitsuru Nenoi; Mizuki Ohno; Daisuke Yoshimura; Sugako Oka; Yusaku Nakabeppu; Kouichi Tatsumi; Masahiro Muto; Toshihiko Sado
Journal:  J Radiat Res       Date:  2013-01-07       Impact factor: 2.724

7.  Indirect induction of radiation lymphomas in mice. Evidence for a novel, transmissible leukemogen.

Authors:  M Lieberman; G A Hansteen; J M McCune; M L Scott; J H White; I L Weissman
Journal:  J Exp Med       Date:  1987-12-01       Impact factor: 14.307

8.  Carcinogenicity of sublimed urethane in mice through the respiratory tract.

Authors:  T Nomura; T Hayashi; T Masuyama; S Tanaka; H Nakajima; N Kurokawa; Y Isa
Journal:  Jpn J Cancer Res       Date:  1990-08

9.  Requirement of dendritic cells and B cells in the clonal deletion of Mls-reactive T cells in the thymus.

Authors:  O Mazda; Y Watanabe; J Gyotoku; Y Katsura
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

10.  Analysis of early initiating event(s) in radiation-induced thymic lymphomagenesis.

Authors:  M Muto; Y Chen; E Kubo; K Mita
Journal:  Jpn J Cancer Res       Date:  1996-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.